Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 10,572 | 10,260 | 9,922 | 8,105 | 7,255 |
| Operating Income | -10,572 | -10,260 | -9,922 | -8,105 | -7,255 |
| Other Income | 415 | 2,262 | 25,115 | -4,008 | -32,962 |
| Pre-tax Income | -10,157 | -7,998 | 15,193 | -12,113 | -40,217 |
| Net Income Continuous | -10,157 | -7,998 | 15,193 | -12,113 | -40,217 |
| Net Income | $-10,157 | $-7,998 | $15,193 | $-12,113 | $-40,217 |
| EPS Basic Total Ops | -0.12 | -0.10 | 0.21 | -0.23 | -0.60 |
| EPS Basic Continuous Ops | -0.12 | -0.10 | 0.21 | -0.23 | -0.60 |
| EPS Diluted Total Ops | -0.12 | -0.10 | -0.13 | -0.23 | -0.60 |
| EPS Diluted Continuous Ops | -0.12 | -0.10 | 0.20 | -0.23 | -0.60 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.10 | -0.13 | -0.18 | -0.11 |
| EBITDA(a) | $-11,003 | $-10,565 | $-10,191 | $-8,327 | $-7,758 |